An NIH-backed study reported in 2 papers in the New England Journal of Medicine shows that the diabetes treatments insulin glargine and liraglutide more effectively maintain target blood sugar levels than sitagliptin or glimepiride when added to first-line metformin.

The U.S. Preventive Services Task Force (USPSTF) has released draft recommendations calling for all adult medical patients younger than age 65 years to undergo screening for anxiety.

The latest findings from the Pharmacy Workplace and Well-being Reporting (PWWR) initiative, which was launched by APhA and the National Alliance of State Pharmacy Associations (NASPA) last fall, are now available.

A study by researchers at Harvard has identified the presence of SARS-CoV-2’s spike protein in the blood of long COVID patients up to 1 year after infection, but not in people who fully recovered from the disease.

In response to the Dobbs v. Jackson ruling, APhA has created numerous resources to help pharmacists navigate the nuances of how pharmacy practice has been affected.